Market position and operating model
Collaborative Drug Discovery presents CDD Vault as a hosted research informatics platform for chemical and biological data registration, assay data, analysis, collaboration, and electronic notebook workflows.
Its drug-discovery data model provides a specialist contrast to general ELN and sample-centered LIMS products.
The primary classification describes where Collaborative Drug Discovery begins in the buyer's operating problem. It does not imply that every module, jurisdiction, workflow, integration, service, or data dependency is interchangeable with another organization in the same category. Buyers should confirm the exact product, edition, service boundary, and accountable party included in a proposal.
Who should evaluate Collaborative Drug Discovery
Drug-discovery and translational research teams managing chemical and biological registration, assay results, collaborative data, and ELN records.
A strong evaluation begins with a real scenario and its exception path. Ask the organization to identify inputs, authoritative content, configured rules, decision owners, handoffs, evidence retained, exports available, and the behavior when required data is missing or contradictory.
Documented capability record
| Capability | Evidence state | What remains to verify |
|---|---|---|
| Sample Registration Identity And Lifecycle Management Open provider-specific evidence record → | Documented in approved official positioning | Depth, package, configuration, data dependency, and production behavior require further verification. |
| Result Capture Calculation Review And Approval Open provider-specific evidence record → | Documented in approved official positioning | Depth, package, configuration, data dependency, and production behavior require further verification. |
| Inventory Reagent Standard And Consumable Management | Documented in approved official positioning | Depth, package, configuration, data dependency, and production behavior require further verification. |
| ELN Experiment Authoring And Collaboration | Documented in approved official positioning | Depth, package, configuration, data dependency, and production behavior require further verification. |
| Chemical Biological And Material Entity Registration | Documented in approved official positioning | Depth, package, configuration, data dependency, and production behavior require further verification. |
| Protocol Method Template And Version Management | Documented in approved official positioning | Depth, package, configuration, data dependency, and production behavior require further verification. |
| Scientific Data Models Ontology And Semantic Context | Documented in approved official positioning | Depth, package, configuration, data dependency, and production behavior require further verification. |
| Scientific Search Analytics And Data Reuse | Documented in approved official positioning | Depth, package, configuration, data dependency, and production behavior require further verification. |
| Electronic Signatures Audit Trails And Record History | Documented in approved official positioning | Depth, package, configuration, data dependency, and production behavior require further verification. |
| Role Identity Access And Segregation-Of-Duties Controls | Documented in approved official positioning | Depth, package, configuration, data dependency, and production behavior require further verification. |
| API Integration And Enterprise Interoperability | Documented in approved official positioning | Depth, package, configuration, data dependency, and production behavior require further verification. |
| Deployment Administration Change Control And Validation Support | Documented in approved official positioning | Depth, package, configuration, data dependency, and production behavior require further verification. |
Known evidence limits
No independent test established assay-data quality, registration behavior, regulated configuration, analytical validity, integration depth, or outcomes.
A documented capability means a current official source supports relevant positioning. It is not an independent observation of configured behavior, accuracy, completeness, latency, usability, implementation effort, integration depth, support quality, customer outcome, or legal and regulatory fitness. Missing public evidence remains not established; it is not silently converted into feature absent.
Enterprise demonstration agenda
- Confirm the precise product, edition, service, geography, and customer population under evaluation.
- Trace one representative case from intake through decision, exception, evidence retention, reporting, and downstream exchange.
- Repeat the workflow with missing data, a conflicting rule or record, a changed authority source, and a user override.
- Identify which content, interpretation, configuration, integration, review, approval, and validation responsibilities remain with the customer or another party.
- Export the decision history and reconcile it to the governing source, configured version, user action, timestamps, and affected records.
Questions to take into diligence
- Which named workflows and capabilities are available in the proposed package today?
- Which authority, content, data, or network dependencies are maintained by the provider, a partner, or the customer?
- How are changes detected, assessed, tested, approved, released, and preserved historically?
- What implementation roles, controlled configurations, integrations, migrations, and ongoing services are required?
- What can an auditor, regulator, clinical reviewer, compliance owner, or operational leader reconstruct from the exported record?
Source and research record
The dossier uses 19 normalized record elements and 1 linked evidence records internally. Those operational totals are not presented as a quality score. The decision-relevant public record is the claim, its source, evidence class, scope, and limitation.
- Collaborative Drug Discovery official product recordprimary · monitored monthly